Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Resource Type
Article
Authors
Matasar, Matthew J ; Capra, Marcelo ; Özcan, Muhit ; Lv, Fangfang ; Li, Wei ; Yañez, Eduardo ; Sapunarova, Katya ; Lin, Tongyu ; Jin, Jie ; Jurczak, Wojciech ; Hamed, Aryan ; Wang, Ming-Chung ; Baker, Ross ; Bondarenko, Igor ; Zhang, Qingyuan ; Feng, Jifeng ; Geissler, Klaus ; Lazaroiu, Mihaela ; Saydam, Guray ; Szomor, Árpád ; Bouabdallah, Krimo ; Galiulin, Rinat ; Uchida, Toshiki ; Soler, Lidia Mongay ; Cao, Anjun ; Hiemeyer, Florian ; Mehra, Aruna ; Childs, Barrett H ; Shi, Yuankai ; Zinzani, Pier Luigi
Source
In The Lancet Oncology May 2021 22(5):678-689
Subject
Primary Research Articles
Language
ISSN
1470-2045